clinical trials

New Business

China’s clinical trial capacity matches US, attracts more global pharma firms, investors

China’s growing pipeline of novel drug candidates is expected to draw increased attention from global pharmaceutical companies and investors scouting…

Read More »
New Business

China’s southwestern industrial base eyes breakthroughs on novel drugs

Chongqing, a key economic hub in southwest China, has unveiled a plan to support the development of innovative drugs as…

Read More »
Tech

Yifan Pharma’s unit, eyeing US$5.5 billion post-chemotherapy treatment market dominated by Amgen, considers IPO in 2021

Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…

Read More »
Back to top button